Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.


BIO’s New Bioscience Report Shows Industry Creating Jobs, Driving Innovation in U.S. and New Jersey

BIO Logo New NameWashington, DC, June 9, 2016 ― At its BIO International Convention this week in San Francisco, the Biotechnology Innovation Organization (BIO) released a study — “The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life 2016” — that shows increased employment within the United States bioscience industry for the last four consecutive years.

The report also shows that New Jersey’s economy is 89 percent more concentrated in the biosciences than the national average and this high degree of specialization spans four of the five major industry subsectors: drugs and pharmaceuticals; research, testing, and medical labs; bioscience-related distribution; and medical devices.

The report also shows impressive U.S. bioscience industry strength and resilience, with employment growth of nearly 10 percent since 2001.  Among technology sectors the bioscience industry has been a leading performer over this period. Continue reading

Biotechnology Industry Organization Changes Name to Biotechnology Innovation Organization

BIO Logo New NameWashington, DC, January 5, 2016 ― To better reflect the remarkable progress and groundbreaking innovations its members achieve in healing, fueling and feeding the world, BIO — the world’s largest biotechnology trade association — is changing its name to Biotechnology Innovation Organization.

The organization will continue to use the shortened, “BIO” name.

In the more than 22 years since its founding, BIO has united scientists, entrepreneurs, policymakers and the public to advance breakthrough cures and products in fields ranging from health, food and agricultural to industrial and environmental. Continue reading

Biopharma Trade Groups Ask US Supreme Court to Review California County Drug Take-Back Program

New York, NY, January 7, 2015 ― Pharmalot reports that, angry over a drug take-back program instituted by a California county, the pharmaceutical industry has asked the US Supreme Court to review the constitutionality of the program.

In a filing on December 29, three trade groups — the Pharmaceutical Research and Manufacturers of America (PhRMA), the Generic Pharmaceuticals Association (GPhA) and the Biotechnology Industry Organization (BIO) — argue that a federal appeals court erred last September when it upheld a lower-court ruling that the program did not violate the Constitution.

The trade groups maintain that Alameda County interfered with interstate commerce and discriminates against out-of-state drug makers. Continue reading